Lipid-lowering--translating evidence into benefits

Atheroscler Suppl. 2002 Apr;2(4):1-3. doi: 10.1016/s1567-5688(01)00015-0.

Authors

James Shepherd¹, Philip Barter

Affiliation

¹ Department of Pathological Biochemistry, University of Glasgow Royal Infirmary, Glasgow, Scotland, UK.

PMID: 11976070
DOI: 10.1016/s1567-5688(01)00015-0

No abstract available

MeSH terms

Coronary Disease / blood*
Coronary Disease / prevention & control*
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Lipids / blood*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids